Get the Stockscreener App
10.12
0.39%
-0.04
Liquidia Corp stock is traded at $10.12, with a volume of 718.34K.
It is down -0.39% in the last 24 hours and down -9.16% over the past month.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
See More
Previous Close:
$10.16
Open:
$10.15
24h Volume:
718.34K
Relative Volume:
0.75
Market Cap:
$856.52M
Revenue:
$17.49M
Net Income/Loss:
$-78.50M
P/E Ratio:
-13.14
EPS:
-0.77
Net Cash Flow:
$-52.85M
1W Performance:
-1.46%
1M Performance:
-9.16%
6M Performance:
-24.19%
1Y Performance:
+55.69%
1-Day Range:
$9.96
$10.31
1-Week Range:
$9.71
$10.68
52-Week Range:
$6.42
$16.99
Liquidia Corp Stock (LQDA) Company Profile
Name
Liquidia Corp
Sector
Industry
Phone
919.328.4400
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| LQDA | 10.12 | 856.52M | 17.49M | -78.50M | -52.85M | -0.77 |
| VRTX | 451.23 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 743.35 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.82 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.79 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.14 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-19-22 | Resumed | Wedbush | Underperform |
| Sep-01-22 | Downgrade | Wedbush | Neutral → Underperform |
| Jul-22-22 | Initiated | Ladenburg Thalmann | Buy |
| May-31-22 | Initiated | BTIG Research | Buy |
| May-26-22 | Initiated | BofA Securities | Buy |
| Dec-04-20 | Initiated | H.C. Wainwright | Buy |
| Nov-20-20 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-08-18 | Resumed | Jefferies | Buy |
| Sep-05-18 | Initiated | Wedbush | Outperform |
| Aug-20-18 | Initiated | Jefferies | Buy |
| Aug-20-18 | Initiated | Needham | Buy |
View All
Liquidia Corp Stock (LQDA) Latest News
FY2024 EPS Estimates for Liquidia Raised by Lifesci Capital - MarketBeat
FY2024 EPS Estimates for Liquidia Boosted by HC Wainwright - MarketBeat
Liquidia Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Liquidia (NASDAQ:LQDA) Receives Buy Rating from Needham & Company LLC - MarketBeat
The Analyst Landscape: 11 Takes On Liquidia - Benzinga
Liquidia Corporation (NASDAQ:LQDA) Q3 2024 Earnings Call Transcript - Insider Monkey
Q3 2024 Liquidia Corp Earnings Call Transcript - GuruFocus.com
Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory Challenges - GuruFocus.com
Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ... - Yahoo Finance
Liquidia Technologies earnings beat by $0.07, revenue topped estimates - Investing.com
Liquidia Corp Q3 2024 Earnings: Revenue Hits $4.4M, EPS at $(0.3 - GuruFocus.com
Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance
Uncovering Potential: Liquidia's Earnings Preview - Benzinga
Liquidia to Present at the Stifel 2024 Healthcare Conference - Yahoo Finance
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.69% - Investing.com
Earnings To Watch: Liquidia Corp (LQDA) Reports Q3 2024 Result - GuruFocus.com
Investors in Liquidia (NASDAQ:LQDA) have seen stellar returns of 186% over the past five years - Yahoo Finance
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024 - Yahoo Finance
Liquidia (LQDA) to Release Quarterly Earnings on Monday - MarketBeat
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024 - Yahoo Finance
Liquidia Corp's chief business officer sells shares worth $5,190 - Investing.com India
Liquidia Corp's chief business officer sells shares worth $5,190 By Investing.com - Investing.com Australia
Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Analysts Set Liquidia Co. (NASDAQ:LQDA) PT at $24.67 - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia CorporationLQDA - PR Newswire
Rajeev Saggar Sells 2,526 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat
Liquidia CEO Roger Jeffs sells $89,450 in stock By Investing.com - Investing.com South Africa
Liquidia's chief business officer sells $12,729 in stock By Investing.com - Investing.com South Africa
Liquidia's chief commercial officer sells $16,961 in stock By Investing.com - Investing.com South Africa
Liquidia's chief business officer sells $12,729 in stock - Investing.com India
Liquidia's chief commercial officer sells $16,961 in stock - Investing.com India
Liquidia corp CFO Michael Kaseta sells $43,231 in stock - Investing.com India
Liquidia corp CFO Michael Kaseta sells $43,231 in stock By Investing.com - Investing.com Australia
Liquidia Corp (LQDA) rating upgrades by Raymond James - Knox Daily
Liquidia's general counsel Russell Schundler sells shares worth $28,613 By Investing.com - Investing.com Australia
Liquidia's chief medical officer sells $25,103 in stock By Investing.com - Investing.com Canada
Liquidia's general counsel Russell Schundler sells shares worth $28,613 - Investing.com India
Liquidia's chief medical officer sells $25,103 in stock - Investing.com India
Russell Schundler Sells 2,576 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat
Liquidia CEO Roger Jeffs sells $89,450 in stock - Investing.com
Daily Market Movement: Liquidia Corp (LQDA) Sees a 0.45 Increase, Closing at 11.14 - The Dwinnex
A year in review: Liquidia Corp (LQDA)’s performance in the last year - US Post News
Check out these key findings about Liquidia Corp (LQDA) - SETE News
Liquidia Corp [LQDA] Shares Fall -0.54 % on Thursday - Knox Daily
Financial Metrics Check: Liquidia Corp (LQDA)’s Ratios for Trailing Twelve Months - The Dwinnex
Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ... - Yahoo Finance
Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigatin - GuruFocus.com
Liquidia Corp (LQDA) shows promising results - US Post News
Liquidia Corp Stock (LQDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.69%
6.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):